Royal Bank of Canada’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$190K Buy
18,300
+15,915
+667% +$165K ﹤0.01% 4870
2025
Q1
$31K Sell
2,385
-3,077
-56% -$40K ﹤0.01% 5382
2024
Q4
$98K Buy
5,462
+2,524
+86% +$45.3K ﹤0.01% 4891
2024
Q3
$47K Buy
2,938
+125
+4% +$2K ﹤0.01% 5267
2024
Q2
$76K Buy
2,813
+595
+27% +$16.1K ﹤0.01% 5049
2024
Q1
$44K Sell
2,218
-1,622
-42% -$32.2K ﹤0.01% 5148
2023
Q4
$79K Sell
3,840
-434
-10% -$8.93K ﹤0.01% 5224
2023
Q3
$136K Buy
4,274
+1,391
+48% +$44.3K ﹤0.01% 4659
2023
Q2
$97K Buy
2,883
+355
+14% +$11.9K ﹤0.01% 4926
2023
Q1
$105K Buy
2,528
+13
+0.5% +$540 ﹤0.01% 4768
2022
Q4
$86K Sell
2,515
-10
-0.4% -$342 ﹤0.01% 5099
2022
Q3
$124K Buy
2,525
+25
+1% +$1.23K ﹤0.01% 4691
2022
Q2
$98K Sell
2,500
-205
-8% -$8.04K ﹤0.01% 4887
2022
Q1
$100K Sell
2,705
-384
-12% -$14.2K ﹤0.01% 5171
2021
Q4
$303K Buy
3,089
+295
+11% +$28.9K ﹤0.01% 4418
2021
Q3
$349K Buy
2,794
+63
+2% +$7.87K ﹤0.01% 4169
2021
Q2
$343K Buy
2,731
+66
+2% +$8.29K ﹤0.01% 4154
2021
Q1
$361K Buy
2,665
+66
+3% +$8.94K ﹤0.01% 3996
2020
Q4
$236K Buy
2,599
+2,581
+14,339% +$234K ﹤0.01% 4225
2020
Q3
$1K Buy
+18
New +$1K ﹤0.01% 5974
2018
Q4
Sell
-11
Closed -$5K 6060
2018
Q3
$5K Buy
11
+1
+10% +$455 ﹤0.01% 5663
2018
Q2
$4K Buy
+10
New +$4K ﹤0.01% 5524
2018
Q1
Sell
-1
Closed 5921
2017
Q4
$0 Sell
1
-41
-98% ﹤0.01% 5982
2017
Q3
$23K Buy
+42
New +$23K ﹤0.01% 5131
2017
Q2
Sell
-11
Closed -$5K 5915
2017
Q1
$5K Buy
11
+1
+10% +$455 ﹤0.01% 5534
2016
Q4
$5K Buy
10
+7
+233% +$3.5K ﹤0.01% 5533
2016
Q3
$1K Buy
+3
New +$1K ﹤0.01% 5532